PTC Therapeutics (PTCT) Provides Regulatory Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/18/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. NEST:IN
10. AA

Go back to PTC Therapeutics (PTCT) Provides Regulatory Updates

PTC Therapeutics Provides Key Regulatory Updates

March 19, 2024 7:30 AM EDT

- BLA submitted to FDA for Upstaza for the treatment of AADC deficiency -

- NDA to be submitted mid-year for Translarna based on FDA feedback -

SOUTH PLAINFIELD, N.J., March 19, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the submission of a BLA to the U.S. FDA for Upstaza (eladocagene exuparvovec), a gene therapy for the treatment of... More